These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24325692)

  • 1. Commentary: nitinol stents for femoropopliteal disease: what is the view from the SUMMIT?
    Armstrong EJ
    J Endovasc Ther; 2013 Dec; 20(6):767-9. PubMed ID: 24325692
    [No Abstract]   [Full Text] [Related]  

  • 2. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
    Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
    J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on "Incidence and clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year".
    Chaudhuri A
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):213. PubMed ID: 23810705
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement.
    Gökgöl C; Schumann S; Diehm N; Zheng G; Büchler P
    J Endovasc Ther; 2017 Feb; 24(1):27-34. PubMed ID: 28095767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
    Kralj I; Boos I; Müller-Bühl U
    Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regarding 'the impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial'.
    Galyfos G; Sigala F; Filis K
    Ann Vasc Surg; 2014 May; 28(4):1083-4. PubMed ID: 24530713
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year clinical outcomes of stent fractures following primary femoropopliteal stenting.
    Albayati MA; Shearman CP; Nordon IM
    Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):601. PubMed ID: 24053904
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: comparative effectiveness of paclitaxel-based femoropopliteal interventions.
    Armstrong EJ
    J Endovasc Ther; 2014 Jun; 21(3):369-72. PubMed ID: 24915583
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
    Chan YC; Cheng SW; Ting AC; Cheung GC
    J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: intravascular ultrasound for femoropopliteal stenting: can it predict outcomes with current-generation stents?
    Foley TR; Armstrong EJ
    J Endovasc Ther; 2015 Jun; 22(3):350-1. PubMed ID: 25904483
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: Role of Self-Expanding Stents in Infrapopliteal Artery Disease.
    Jafferani A; Dieter RS
    J Endovasc Ther; 2015 Oct; 22(5):698-700. PubMed ID: 26392474
    [No Abstract]   [Full Text] [Related]  

  • 14. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture of a Supera Interwoven Nitinol Stent After Treatment of Popliteal Artery Stenosis.
    Cambiaghi T; Spertino A; Bertoglio L; Chiesa R
    J Endovasc Ther; 2017 Jun; 24(3):447-449. PubMed ID: 28351226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eComment. Drug-eluting stents versus angioplasty with or without bare metal stents in infra-inguinal arterial diseas.
    Mouawad NJ
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):285. PubMed ID: 25035506
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of Usefulness of Drug Coated Balloon Versus Standard Balloon in the Treatment of Femoropopliteal In-Stent-Restenosis.
    Doshi R; Kumar A; Adalja D; Vaz I; Shariff M
    Am J Cardiol; 2020 Oct; 133():170-171. PubMed ID: 32778336
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.